Related Experiment Videos
The Mre11 complex and ATM: collaborating to navigate S phase
1University of Wisconsin Medical School, Madison, WI 53706, USA. jpetrini@facstaff.wisc.edu
Current Opinion in Cell Biology
|May 10, 2000
Summary
Recombinational DNA repair proteins, like the Mre11 complex, play a crucial role in cell-cycle regulation following DNA damage. Mutations in Mre11 cause Nijmegen breakage syndrome (NBS) and ataxia-telangiectasia-like disorder (A-TLD).
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Cancer predisposition and chromosome instability syndromes, including Nijmegen breakage syndrome (NBS), ataxia-telangiectasia-like disorder (A-TLD), and ataxia-telangiectasia (A-T), are linked to DNA repair pathways.
- The Mre11 complex is implicated in these syndromes, with mutations causing NBS and A-TLD.
- The ATM kinase is defective in A-T cells, highlighting its importance in DNA damage response.
Purpose of the Study:
- To elucidate the role of recombinational DNA repair proteins in DNA-damage-dependent cell-cycle regulation.
- To understand the functional relationship between the Mre11 complex and the ATM kinase.
Main Methods:
- Analysis of mutations in the Mre11 complex associated with NBS and A-TLD.
- Biochemical studies linking the Mre11 complex functions to ATM kinase activity.
- Investigating Nbs1 as a substrate of the ATM kinase.
Main Results:
- Mutations in the Mre11 complex are causative for ataxia-telangiectasia-like disorder (A-TLD) and Nijmegen breakage syndrome (NBS).
- The Mre11 complex's functions are biochemically associated with the ATM kinase.
- Nbs1 has been identified as a direct substrate of the ATM kinase.
Conclusions:
- Recombinational DNA repair proteins, particularly the Mre11 complex, are unexpectedly involved in cell-cycle regulation in response to DNA damage.
- The Mre11 complex and ATM kinase pathways are interconnected, crucial for maintaining genomic stability.
- These findings provide insights into the molecular mechanisms underlying NBS, A-TLD, and A-T.